Astellas Pharma
ALPMY----
Astellas Pharma (ALPMY)
Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for p...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Astellas Pharma Analyst Rating
View MoreForecast & Rating
Jun 4, 2026Price forecast
$17.4030.88%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- prnewswire · 1 day ago, 04:37 PM
17:36 ETThe Inner Circle acknowledges Shankari Thiagarajan as Pinnacle Professional of The Year
- PharmaTimes · Jul 13 at 07:07 AM
SMC recommends VEOZA for moderate to severe menopausal vasomotor symptoms
- PUBT · Jul 10 at 10:23 AM
FDA approves Pfizer PADCEV-Keytruda combo for perioperative muscle-invasive bladder cancer
- rttnews · Jun 26 at 08:59 AM
Lupin Wins FDA's Tentative Approval For Enzalutamide Tablets Across Multiple Strengths
- biopharmadive · Jun 24 at 09:32 AM
Sangamo holds a bankruptcy sale; VCs back a China-linked Beam competitor
- PUBT · Jun 23 at 03:42 PM
Sangamo amends 8-K to file asset purchase agreement exhibits
